Resveratrol suppresses tumor necrosis factor-α-induced fractalkine expression in endothelial cells

Molecular Pharmacology

Volumn 70, Issue 1, 2006, Pages 112-119

  Moon, Sang Ok ^a   Kim, Won ^a   Mi, Jeong Sung ^a   Lee, Sik ^a   Kyung, Pyo Kang ^a   Duk, Hoon Kim ^a   Sang, Yong Lee ^a   So, June No ^b   Sung, Kwang Park ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Woosuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; FRACTALKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL INFILTRATION; CELL LINE; CONTROLLED STUDY; CYTOMETRY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; CELLS, CULTURED; CHEMOKINES, CX3C; ECTODYSPLASINS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; INTESTINES; KIDNEY; MACROPHAGES; MEMBRANE PROTEINS; MICROVILLI; MONOCYTES; MYOCARDIUM; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE; RNA, MESSENGER; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 33745273633     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.022392     Document Type: Article

References (40)

1. Ahn SY, Cho CH, Park KG, Lee HJ, Lee S, Park SK, Lee IK, and Koh GY (2004) Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am J Pathol 164:1663-1672.
2. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, Luscinskas FW, and Gabuzda D (2003) Fractalkine preferentially mediates arrest and migration of CD16 monocytes. J Exp Med 197:1701-1707.
3. Araim O, Ballantyne J, Waterhouse AL, and Sumpio BE (2002) Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols. J Vasc Surg 35:1226-1232.
4. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, and Arichi S (1982) Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull (Tokyo) 30:1766-1770.
5. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, and Schall TJ (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature (Lond) 385:640-644.
6. Bertelli AA, Baccalini R, Battaglia E, Falchi M, and Ferrero ME (2001) Resveratrol inhibits TNF alpha-induced endothelial cell activation. Therapie 56:613-616.
7. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, et al. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561.
8. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debre P, Tedgui A, Murphy PM, and Mallat Z (2003) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107:1009-1016.
9. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, and Merillon JM (1997) Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61:2103-2110.
10. Ferrero ME, Bertelli AA, Pellegatta F, Fulgenzi A, Corsi MM, and Bertelli (1998) A Phytoalexin resveratrol (3-4′-5-trihydroxystilbene) modulates granulocyte and monocyte endothelial adhesion. Transplant Proc 30:4191-4193.
11. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, and Patel DD (1998) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion and activation under physiologic flow. J Exp Med 188:1413-1419.
12. Foussat A, Bouchet-Delbos L, Berrebi D, Durand-Gasselin I, Coulomb-L'Hermine A, Krzysiek R, Galanaud P, Levy Y, and Emilie D (2001) Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. Blood 98:1678-1686.
13. Foussat A, Coulomb-L'Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Galanaud P, and Emilie D (2000) Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30:87-97.
14. Frankel EN, Waterhouse AL, and Kinsella JE (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103-1104.
15. Fujiwara N and Kobayashi K (2005) Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4:281-286.
16. Garcia GE, Xia Y, Chen S, Wang Y, Ye RD, Harrison JK, Bacon KB, Zerwes HG, and Feng L (2000) NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha and LPS. J Leukoc Biol 67:577-584.
17. Gimbrone MA Jr, Nagel T, and Topper JN (1997) Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Investig 99:1809-1813.
18. Goldberg DM, Hahn SE, and Parkes JG (1995) Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 237:155-187.
19. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, et al. (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95:10896-10901.
20. Haskell CA, Cleary MD, and Charo IF (1999) Molecular uncoupling of fractalkinemediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem 274:10053-10058.
21. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, et al. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521-530.
22. 2 inhibits CX3CL1/fractalkine expression in human endothelial cells. Immunol Cell Biol 80:531-536.
23. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (Wash DC) 275:218-220.
24. Kim W, Moon SO, Lee S, Sung MJ, Kim SH, and Park SK (2003) Adrenomedullin reduces VEGF-induced endothelial adhesion molecules and adhesiveness through a phosphatidylinositol 3′-kinase pathway. Arterioscler Thromb Vasc Biol 23:1377-1383.
25. Lesnik P, Haskell CA, and Charo IF (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Investig 111:333-340.
26. Manna SK, Mukhopadhyay A, and Aggarwal BB (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1 and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164:6509-6519.
27. Matsumiya T, Imaizumi T, Fujimoto K, Cui X, Shibata T, Tamo W, Kumagai M, Tanji K, Yoshida H, Kimura H, et al. (2001) Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture. Exp Cell Res 269:35-41.
28. Mazzucchelli R, Amadio M, Curreli S, Denaro F, Bemis K, Reid W, Bryant J, Riva A, Galli M, and Zella D (2004) Establishment of an ex vivo model of monocytesderived macrophages differentiated from peripheral blood mononuclear cells (PBMCs) from HIV-1 transgenic rats. Mol Immunol 41:979-984.
29. Moatti D, Faure S, Fumeron F, Amara Mel W, Seknadji P, McDermott DH, Debre P, Aumont MC, Murphy PM, de Prost D, et al. (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925-1928.
30. Nanki T, Urasaki Y, Imai T, Nishimura M, Muramoto K, Kubota T, and Miyasaka N (2004) Inhibition of fractalkine ameliorates murine collagen-induced arthritis. J Immunol 173:7010-7016.
31. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, and Goldberg DM (1996) Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 246:163-182.
32. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma J, Dussault B, et al. (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (Lond) 387:611-617.
33. Pellegatta F, Bertelli AA, Staels B, Duhem C, Fulgenzi A, and Ferrero ME (2003) Different short- and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells. Am J Clin Nutr 77:1220-1228.
34. Pendurthi UR and Rao LV (2002) Resveratrol suppresses agonist-induced monocyte adhesion to cultured human endothelial cells. Thromb Res 106:243-248.
35. Robinson LA, Nataraj C, Thomas DW, Howell DN, Griffiths R, Bautch V, Patel DD, Feng L, and Coffman TM (2000) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165:6067-6072.
36. Ross R (1999) Atherosclerosis- an inflammatory disease. N Engl J Med 340:115-126.
37. Segerer S, Hughes E, Hudkins KL, Mack M, Goodpaster T, and Alpers CE (2002) Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 62:488-495.
38. Sung MJ, Kim W, Ahn SY, Cho CH, Koh GY, Moon SO, Kim DH, Lee S, Kang KP, Jang KY, et al. (2005) Protective effect of alpha-lipoic acid in lipopolysaccharideinduced endothelial fractalkine expression. Circ Res 97:880-890.
39. Tsai SH, Lin-Shiau SY, and Lin JK (1999) Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 126:673-680.
40. Yamashita K, Imaizumi T, Hatakeyama M, Tamo W, Kimura D, Kumagai M, Yoshida H, and Satoh K (2003) Effect of hypoxia on the expression of fractalkine in human endothelial cells. Tohoku J Exp Med 200:187-194.